Choose your screen resolution: Auto adjust 800x600 1024x768

Information

Login

No account yet? Register

Please Visit

Advertisement

In the News

Filter     Order     Display # 
Item Title Hits
MMSupport.net unveils “Ask the Expert”, featuring Dr. James R. Berenson 2502
Stem cells make bone marrow cancer resistant to treatment 2163
Norepinephrine could hasten the progression of certain blood cancers 2279
Researchers to Investigate Ways to Better Diagnose Autoimmune Disorders 2062
Velcade Before and After SCT for Newly Diagnosed 2738
Research From Cleveland Clinic Provides New Insights Into Relapsed Or Refractory Multiple Myeloma 2895
Mayo Clinic Cancer Center Researchers Find That a Byproduct of Mold Kills Multiple Myeloma 3266
Mayo Clinic Cancer Center -- Investigating the Measles Virus as a Tool to Kill Multiple Myeloma 2816
A chemotherapy drug packs a one-two punch 2954
New Findings from the Mayo Clinic 3291
Circulating Cancer Cells Indicate Worse Outcomes Following Autologous Stem Cell Transplant 3478
An advanced genetic diagnostic method for multiple myeloma 1042
Drug Fights Multiple Myeloma by Putting "Brakes" on Cell Proliferation, Weill Cornell Team Reports 1214
Gene Called Link Between Life Span and Cancers 889
REVLIMID(R) in Combination With Dexamethasone sNDA Granted Approval By FDA for Treatment of MM 1169
REVLIMID (R) (Lenalidomide) Survival Data Evaluated in Previously Treated Multiple Myeloma 1103
Revlimid boosts survival in multiple myeloma-study 1110
New Drugs for Cancer Could Soon Flood Market 1097
Thalidomide approved for cancer treatment 1073
FDA approves Merck's shingles vaccine 947
A Strain of Mice Appears Able to Resist Cancer Cells 1113
Mini Allogeneic Transplant Not Superior to Subsequent Autologous Stem Cell Transplant in High-Risk M 925
UAMS Myeloma Researchers on Team Analyzing Disease's Genetic Fingerprints -- Cancer Cell Publishes W 1048
Scientists discover new genetic sub-types of blood cancer 1151
Study shows rituximab effective in treating chronic graft-versus-host disease 959
Study Describes Osteonecrosis of the Jaw in Patients with Multiple Myeloma 1147
Velcade® plus Melphalan Shows Encouraging Activity in Multiple Myeloma 1056
Treanda™/Prednisone Superior to Melphalan/Prednisone for Multiple Myeloma 1461
Low Dose of Thalidomid® as Effective as Higher Dose in Relapsed Myeloma 1126
Osteonecrosis of the jaw associated with pamidronate therapy 1510
Weill Cornell Team Identifies Mechanism Triggering Multiple Myeloma Relapse 1666
Revolutionary Approach to Cancer Therapy Should Increase Efficacy 1323
Compound from marine bacteria shows potential as multiple myeloma therapy 1303
Resveratrol Combats Bone Marrow Cancer 1284
Human myeloma cell line suitable for the generation of stable human monoclonal antibodies 1491
Combination of Drugs Shows Promise for Treatment of Multiple Myeloma 1122
A PHASE 1 STUDY OF BORTEZOMIB (VELCADE) IN COMBINATION WITH LENALIDOMIDE (REVLIMID) IN RELAPSED AN 1084
FDA extends review date for Celgene cancer drug 1112
FDA panel backs Celgene's Revlimid 1111
MRI of Bone Marrow Predicts Outcomes of Multiple Myeloma 4998
Scientists say drug is good cancer fighter 1637
Velcade® Overcomes Poor Prognosis of Genetic Mutation in Multiple Myeloma 1379
Revlimid® Delays Time to Cancer Progression in Relapsed Multiple Myeloma 3563
'Smart' Immune Cells Kill More Cancer 2217
Mayo Clinic researchers create 'obedient virus'; First step to use measles virus against cancer 2292
Seattle Genetics Receives Key U.S. Patents for SGN-40 Program 1975
US FDA approves Kepivance for oral mucositis in cancer patients 2216
By impounding iron, FHC foils cell suicide, fuels inflammation 1367
Antisense Drug Targeting STAT-3 Demonstrates Significant Anti-Tumor Activity 1358
Multiple Myeloma Research Consortium launched 2046
 
<< Start < Prev 1 2 Next > End >>
Results 1 - 50 of 88

Search This Site

Tax Deductible Donation

Please support this site and online support for health challenges of all kinds, which are provided by the Online Patient Empowerment Project, a 501(c)(3) Corporation.

Search the Web

Google

Mailing Lists

Have you subscribed to the MMA interactive mailing list?  Please click HERE to subscribe. Once subscribed, you can choose a daily digest version, real time delivery and you'll have access to the list archives. To join the ACOR list, please click HERE.

Syndicate

Statistics

Visitors: 886508

Who's Online